Having trouble accessing articles? Reset your cache.

Vivus sells Muse to Meda

Vivus Inc. (NASDAQ:VVUS) will divest all assets related to erectile dysfunction (ED) drug Muse alprostadil to

Read the full 164 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE